Search research articles
Contact Us
Filters
Showing results (471-480 of 556) with videos related to
Page
of 56
Sort By:
Journal of Surgical Oncology
|
November 1, 1983
Hematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma
M V Agrez, R E Wharen, R E Anderson, et al.
The Journal of Urology
|
July 13, 2010
The association between statin use and the diagnosis of prostate cancer in a population based cohort
Rodney H Breau, R Jeffrey Karnes, Debra J Jacobson, et al.
The Journal of Sexual Medicine
|
July 3, 2009
Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men
Naomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
International Journal of Epidemiology
|
December 1, 1994
The natural history of prostatism: the effects of non-response bias
L A Panser, C G Chute, H A Guess, et al.
BJU International
|
September 1, 2010
Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms
Jennifer L St Sauver, Steven J Jacobsen, Debra J Jacobson, et al.
American Journal of Epidemiology
|
April 28, 2009
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort
Jennifer L St Sauver, Aruna V Sarma, Debra J Jacobson, et al.
Mayo Clinic Proceedings
|
February 3, 2009
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease
Brant A Inman, Jennifer L St Sauver, Debra J Jacobson, et al.
Urology
|
August 11, 1998
Screening digital rectal examination and prostate cancer mortality: a population-based case-control study
S J Jacobsen, E J Bergstralh, S K Katusic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression
Junqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Urology
|
November 25, 2011
Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men
Aruna V Sarma, Jennifer L St Sauver, John M Hollingsworth, et al.
Page
of 56
Search research articles
Search
Showing results (471-480 of 556) with videos related to
Sort By:
Page
of 56
Journal of Surgical Oncology
|
November 1, 1983
Hematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma
M V Agrez, R E Wharen, R E Anderson, et al.
The Journal of Urology
|
July 13, 2010
The association between statin use and the diagnosis of prostate cancer in a population based cohort
Rodney H Breau, R Jeffrey Karnes, Debra J Jacobson, et al.
The Journal of Sexual Medicine
|
July 3, 2009
Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men
Naomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
International Journal of Epidemiology
|
December 1, 1994
The natural history of prostatism: the effects of non-response bias
L A Panser, C G Chute, H A Guess, et al.
BJU International
|
September 1, 2010
Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms
Jennifer L St Sauver, Steven J Jacobsen, Debra J Jacobson, et al.
American Journal of Epidemiology
|
April 28, 2009
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort
Jennifer L St Sauver, Aruna V Sarma, Debra J Jacobson, et al.
Mayo Clinic Proceedings
|
February 3, 2009
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease
Brant A Inman, Jennifer L St Sauver, Debra J Jacobson, et al.
Urology
|
August 11, 1998
Screening digital rectal examination and prostate cancer mortality: a population-based case-control study
S J Jacobsen, E J Bergstralh, S K Katusic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression
Junqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Urology
|
November 25, 2011
Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men
Aruna V Sarma, Jennifer L St Sauver, John M Hollingsworth, et al.
Page
of 56